Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Lawrence Wallace Insider Profile
18 Followers
John Lawrence Wallace, Chief Scientific Officer at Antibe Therapeutics, holds 1.97M shares in Antibe Therapeutics (Ticker: ATBPF). Most recently, John Lawrence Wallace Sold $250,000 shares of Antibe Therapeutics on Dec 17, 2022 for an estimated value of 122.50K.
John Lawrence Wallace Antibe Therapeutics (ATBPF)Chief Scientific Officer
Antibe Therapeutics (ATBPF)
Chief Scientific Officer
Ranked #87,949 out of 98,743 Corporate Insiders
Profitable Transactions
10 out of 20 Profitable Transactions
Average Return
-16.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of John Lawrence Wallace's holdings
Insider Roles
Chief Scientific Officer
Roles that John Lawrence Wallace holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 17, 2019 - May 17, 2020
Return:+90.50%
The most profitable trade made by John Lawrence Wallace
John Lawrence Wallace's Trading History
List of latest transactions for each holding click on a transaction to see John Lawrence Wallace's performance on stock
You May Also Like
John Lawrence Wallace insider profile FAQ
What is the percentage of profitable transactions made by John Lawrence Wallace?
The percentage of profitable transactions made by John Lawrence Wallace is 50%.
What is the average return per transaction made by John Lawrence Wallace?
The average return per transaction made by John Lawrence Wallace is -16.30%.
What stocks does John Lawrence Wallace hold?
John Lawrence Wallace holds: ATBPF stocks.
What was John Lawrence Wallace’s latest transaction?
John Lawrence Wallace latest transaction was an Informative Sell of $122.50K.
What was John Lawrence Wallace's most profitable transaction?
John Lawrence Wallace’s most profitable transaction was an Informative Buy of ATBPF stock on May 17, 2019. The return on the trade was 90.50%.
What is John Lawrence Wallace's role in Antibe Therapeutics?
John Lawrence Wallace's role in Antibe Therapeutics is Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.